Short News


short news

PSCO honours three oncologists
with Life Time Achievement Awards

KARACHI: Pakistan Society of Clinical Oncology (PSCO) honoured three distinguished oncologists at its annual meeting held at CPSP recently with Life Time Achievement Awards in recognition of their meritorious services in the field of oncology. Those who were selected to be honoured included Prof. S.H. Manzoor Zaidi an eminent oncologist who retired from JPMC many years ago after a long distinguished service and was one of the founder members of the Pakistan Society of Clinical Oncology. He is at present head of Baqai Institute of Oncology, affiliated with Baqai Medical University.

The second person to be honoured was Prof. Abrar Ahmad Javed who retired from Nishter Medical College, Multan and is former President of Pakistan Society of Clinical Oncology. Dr. Shahid Hameed who served at Shaukat Khanum Memorial Cancer Hospital at Lahore for many years and was now working in United States was the third oncologist to be honoured with Life Time Achievement Awards. Detailed report to follow.

Stem cells for heart failure
shows promise

New, accessible therapies are needed to treat millions of patients with debilitating heart failure worldwide. Stem cell transplantation may represent the first realistic strategy for reserving the effects of what has until now been considered terminal damage to the heart.    This was stated by Dr Yasir Qureshi, Assistant Professor and Paediatric Cardiologist at Mayo Clinic College of Medicine, Rochester, Minnesota, USA, during a seminar organized by the Department of Family Medicine, University of Health Sciences (UHS) on September 17.

Dr. Yasir said that congenital heart disease (CHD) occurred in one per cent of liveborn infants, making it the most common birth defect worldwide. He added that in Pakistan every year around 40,000 children were born with (CHD) many of whom eventually develop heart failures.      Dr. Yasir further said that heart transplantation remained the ultimate approach to treating end-stage heart failures, but this therapy was very costly.

He further stated that an additional option for certain congenital heart disease patients in the future might include stem cell therapies. Mayo clinic was conducting the first stem cell clinical trial in the US for paediatric patients with CHD.He informed that the trial focussed on the safety and feasibility of using stem cells to treat children with hypoplastic left cell syndrome. The stem cells collected from the patient’s umbilical cord following birth, would be injected into the patient’s heart muscle that might potentially help these children to grow stronger hearts, Dr Yasir explained.

PHL Symposium at Sukkur
from February 26-28, 2016

SUKKUR: Nineteenth Annual symposium of Pakistan Hypertension League (PHL) will be held at Sukkur from February 26-28, 2016. Dr. Raj Kumar Sachdewani and Prof.  Altaf Ahmed  Sheikh are the Convener and Secretary of the symposium respectively. For details Contact:  Deewan-e-Mushtaq Department of Cardiology GMMMC Sukkur. Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Ph: 071-9310100